Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Savic, Emina (24822544200)"

Filter results by typing the first few letters
Now showing 1 - 11 of 11
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Aloe-emodin inhibits proliferation of adult human keratinocytes in vitro
    (2012)
    Popadic, Dusan (6602255798)
    ;
    Savic, Emina (24822544200)
    ;
    Ramic, Zorica (6603943950)
    ;
    Djordjevic, Vladimir (57189371857)
    ;
    Trajkovic, Vladimir (7004516866)
    ;
    Medenica, Ljiljana (16744100000)
    ;
    Popadic, Svetlana (24830928800)
    Aloe-emodin (AE) is a plant-derived hydroxyanthraquinone with several biological activities. It is present in a variety of skin-conditioning agents containing aloe extracts, but its influence on keratinocyte growth was not examined so far. We investigated the influence of AE on human keratinocyte proliferation and apoptosis in vitro. AE significantly inhibited proliferation of cultivated human keratinocytes at 5 μM concentration, as revealed by incorporation of radioactive thymidine. The antiproliferative effect of AE was accompanied with induction of apoptosis, but not necrosis, as demonstrated by flow cytometric analysis and lactate dehy-drogenase release assay. Based on the half maximal inhibitory concentration values, we demonstrated that AE may impair proliferation of keratinocytes at concentrations far below the industry standards for commercial products containing aloe extracts. Therefore, further research of AE effects on the human skin and proper labeling of products are necessary for maximizing benefits from aloe extracts and to avoid undesired responses. © 2018 Society of Cosmetic Chemists. All Rights Reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Aloe-emodin inhibits proliferation of adult human keratinocytes in vitro
    (2012)
    Popadic, Dusan (6602255798)
    ;
    Savic, Emina (24822544200)
    ;
    Ramic, Zorica (6603943950)
    ;
    Djordjevic, Vladimir (57189371857)
    ;
    Trajkovic, Vladimir (7004516866)
    ;
    Medenica, Ljiljana (16744100000)
    ;
    Popadic, Svetlana (24830928800)
    Aloe-emodin (AE) is a plant-derived hydroxyanthraquinone with several biological activities. It is present in a variety of skin-conditioning agents containing aloe extracts, but its influence on keratinocyte growth was not examined so far. We investigated the influence of AE on human keratinocyte proliferation and apoptosis in vitro. AE significantly inhibited proliferation of cultivated human keratinocytes at 5 μM concentration, as revealed by incorporation of radioactive thymidine. The antiproliferative effect of AE was accompanied with induction of apoptosis, but not necrosis, as demonstrated by flow cytometric analysis and lactate dehy-drogenase release assay. Based on the half maximal inhibitory concentration values, we demonstrated that AE may impair proliferation of keratinocytes at concentrations far below the industry standards for commercial products containing aloe extracts. Therefore, further research of AE effects on the human skin and proper labeling of products are necessary for maximizing benefits from aloe extracts and to avoid undesired responses. © 2018 Society of Cosmetic Chemists. All Rights Reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Expression of TH1 and TH17 cytokines and transcription factors in multiple sclerosis patients: Does baseline T-Bet mRNA predict the response to interferon-beta treatment?
    (2009)
    Drulovic, Jelena (55886929900)
    ;
    Savic, Emina (24822544200)
    ;
    Pekmezovic, Tatjana (7003989932)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Stojsavljevic, Nebojsa (6603086728)
    ;
    Dujmovic-Basuroski, Irena (6701590899)
    ;
    Kostic, Jelena (57159483500)
    ;
    Vasic, Vladimir (32467486300)
    ;
    Stojkovic, Marija Mostarica (6701741422)
    ;
    Popadic, Dusan (6602255798)
    We studied the effect of one-year interferon (IFN)-beta treatment on the in vivo mRNA expression of IFN-γ, interleukin (IL)-17, T-bet and RoR-γt, on peripheral blood mononuclear cells (PBMC) from 36 multiple sclerosis (MS) patients. In the total MS group, IFN-beta induced decrease in mRNA levels of IFN-γ and T-bet (p < 0.0001), while the levels of IL-17 and RoR-γt remained similar. In both responders and non-responders, IFN-beta induced significant decrease of IFN-γ (p < 0.0001 and p = 0.011, respectively), while decrease in T-bet was detected only in responders (p < 0.0001). Higher pre-treatment T-bet allowed prediction of the clinical response in the first year (β = 0.601, p = 0.036). Our preliminary findings suggest that T-bet expression might be a potential prognostic marker of treatment response to IFN-beta in MS. © 2009 Elsevier B.V. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Expression of TH1 and TH17 cytokines and transcription factors in multiple sclerosis patients: Does baseline T-Bet mRNA predict the response to interferon-beta treatment?
    (2009)
    Drulovic, Jelena (55886929900)
    ;
    Savic, Emina (24822544200)
    ;
    Pekmezovic, Tatjana (7003989932)
    ;
    Mesaros, Sarlota (7004307592)
    ;
    Stojsavljevic, Nebojsa (6603086728)
    ;
    Dujmovic-Basuroski, Irena (6701590899)
    ;
    Kostic, Jelena (57159483500)
    ;
    Vasic, Vladimir (32467486300)
    ;
    Stojkovic, Marija Mostarica (6701741422)
    ;
    Popadic, Dusan (6602255798)
    We studied the effect of one-year interferon (IFN)-beta treatment on the in vivo mRNA expression of IFN-γ, interleukin (IL)-17, T-bet and RoR-γt, on peripheral blood mononuclear cells (PBMC) from 36 multiple sclerosis (MS) patients. In the total MS group, IFN-beta induced decrease in mRNA levels of IFN-γ and T-bet (p < 0.0001), while the levels of IL-17 and RoR-γt remained similar. In both responders and non-responders, IFN-beta induced significant decrease of IFN-γ (p < 0.0001 and p = 0.011, respectively), while decrease in T-bet was detected only in responders (p < 0.0001). Higher pre-treatment T-bet allowed prediction of the clinical response in the first year (β = 0.601, p = 0.036). Our preliminary findings suggest that T-bet expression might be a potential prognostic marker of treatment response to IFN-beta in MS. © 2009 Elsevier B.V. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Multiple sclerosis: Individualized disease susceptibility and therapy response
    (2013)
    Pravica, Vera (7003322504)
    ;
    Markovic, Milos (7101935774)
    ;
    Cupic, Maja (15730255400)
    ;
    Savic, Emina (24822544200)
    ;
    Popadic, Dusan (6602255798)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Mostarica-Stojkovic, Marija (6701741422)
    Multiple sclerosis (MS) is a heterogeneous disease in which diverse genetic, pathological and clinical backgrounds lead to variable therapy response. Accordingly, MS care should be tailored to address disease traits unique to each person. At the core of personalized management is the emergence of new knowledge, enabling optimized treatment and disease-modifying therapies. This overview analyzes the promise of genetic and nongenetic biomarkers in advancing decision-making algorithms to assist diagnosis or in predicting the disease course and therapy response in any given MS patient. © 2013 Future Medicine Ltd.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Multiple sclerosis: Individualized disease susceptibility and therapy response
    (2013)
    Pravica, Vera (7003322504)
    ;
    Markovic, Milos (7101935774)
    ;
    Cupic, Maja (15730255400)
    ;
    Savic, Emina (24822544200)
    ;
    Popadic, Dusan (6602255798)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Mostarica-Stojkovic, Marija (6701741422)
    Multiple sclerosis (MS) is a heterogeneous disease in which diverse genetic, pathological and clinical backgrounds lead to variable therapy response. Accordingly, MS care should be tailored to address disease traits unique to each person. At the core of personalized management is the emergence of new knowledge, enabling optimized treatment and disease-modifying therapies. This overview analyzes the promise of genetic and nongenetic biomarkers in advancing decision-making algorithms to assist diagnosis or in predicting the disease course and therapy response in any given MS patient. © 2013 Future Medicine Ltd.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Predictive immunomonitoring-The COST ENTIRE initiative
    (2013)
    Popadic, Dusan (6602255798)
    ;
    Anegon, Ignacio (57207558963)
    ;
    Baeten, Dominique (7003487552)
    ;
    Eibel, Hermann (7004559701)
    ;
    Giese, Thomas (7003343857)
    ;
    Marits, Per (24385323500)
    ;
    Martinez-Caceres, Eva (6701593867)
    ;
    Mascart, Françoise (6603797497)
    ;
    Nestle, Frank (7005117051)
    ;
    Pujol-Borrell, Ricardo (7006729971)
    ;
    Savic, Emina (24822544200)
    ;
    Scheibenbogen, Carmen (7005281782)
    ;
    Seliger, Barbara (56179312300)
    ;
    Thunberg, Sarah (16652542500)
    ;
    Turina, Maureen (55612627000)
    ;
    Villanova, Federica (35799091800)
    ;
    Winqvist, Ola (6603730787)
    ;
    Wikström, Ann-Charlotte (35494680500)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Predictive immunomonitoring-The COST ENTIRE initiative
    (2013)
    Popadic, Dusan (6602255798)
    ;
    Anegon, Ignacio (57207558963)
    ;
    Baeten, Dominique (7003487552)
    ;
    Eibel, Hermann (7004559701)
    ;
    Giese, Thomas (7003343857)
    ;
    Marits, Per (24385323500)
    ;
    Martinez-Caceres, Eva (6701593867)
    ;
    Mascart, Françoise (6603797497)
    ;
    Nestle, Frank (7005117051)
    ;
    Pujol-Borrell, Ricardo (7006729971)
    ;
    Savic, Emina (24822544200)
    ;
    Scheibenbogen, Carmen (7005281782)
    ;
    Seliger, Barbara (56179312300)
    ;
    Thunberg, Sarah (16652542500)
    ;
    Turina, Maureen (55612627000)
    ;
    Villanova, Federica (35799091800)
    ;
    Winqvist, Ola (6603730787)
    ;
    Wikström, Ann-Charlotte (35494680500)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The preoperative activity of Th1 and Th17 cytokine axes in prediction of sepsis after radical cystectomy
    (2011)
    Tulic, Cane (6602213245)
    ;
    Lazic, Miodrag (35929198300)
    ;
    Savic, Emina (24822544200)
    ;
    Popadic, Dusan (6602255798)
    ;
    Djukic, Jelena (54987838400)
    ;
    Spasic, Dusan (54884515100)
    ;
    Markovic, Milos (7101935774)
    ;
    Ramic, Zorica (6603943950)
    ;
    Mostarica-Stojkovic, Marija (6701741422)
    ;
    Trajkovic, Vladimir (7004516866)
    The aim of the study was to correlate the preoperative activity of Th1 and Th17 cytokine axes with the development of sepsis after radical cystectomy. The study involved twenty patients with the infiltrative transitional cell carcinoma of the urinary bladder without previous radiotherapy/chemotherapy, who underwent open radical cystectomy with urinary diversion. Preoperative plasma concentrations of Th1 cytokines interleukin 12 (IL-12) and interferon gamma (IFN-γ), and Th17 cytokines IL-23 and IL-17, were measured using ELISA. Preoperative expression of mRNA for IL-12p35, IFN-γ, IL-23p19 and IL-17 was quantified by real-time RT-PCR using mRNA extracted from peripheral blood mononuclear cells. Eight patients developed postoperative sepsis, diagnosed within two weeks post-operation as systemic inflammatory response syndrome in the presence of local or systemic infection. The preoperative basal plasma concentrations of Th1 and Th17 cytokines were slightly above the detection limits, with a tendency toward lower concentrations in patients who developed sepsis, but the difference was not significant (p>0.05). The preoperative expression of mRNA encoding IL-12p35 and IL-17 was significantly lower in patients who developed sepsis (p=0.003 and p=0.028, respectively). The similar trend was observed for IL-23p19 and IFN-γ, but the differences did not reach the statistical significance (p=0.051 and p=0.172, respectively). These data suggest that determination of preoperative Th1 and Th17 cytokine mRNA levels might be useful in predicting sepsis development after radical cystectomy.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The preoperative activity of Th1 and Th17 cytokine axes in prediction of sepsis after radical cystectomy
    (2011)
    Tulic, Cane (6602213245)
    ;
    Lazic, Miodrag (35929198300)
    ;
    Savic, Emina (24822544200)
    ;
    Popadic, Dusan (6602255798)
    ;
    Djukic, Jelena (54987838400)
    ;
    Spasic, Dusan (54884515100)
    ;
    Markovic, Milos (7101935774)
    ;
    Ramic, Zorica (6603943950)
    ;
    Mostarica-Stojkovic, Marija (6701741422)
    ;
    Trajkovic, Vladimir (7004516866)
    The aim of the study was to correlate the preoperative activity of Th1 and Th17 cytokine axes with the development of sepsis after radical cystectomy. The study involved twenty patients with the infiltrative transitional cell carcinoma of the urinary bladder without previous radiotherapy/chemotherapy, who underwent open radical cystectomy with urinary diversion. Preoperative plasma concentrations of Th1 cytokines interleukin 12 (IL-12) and interferon gamma (IFN-γ), and Th17 cytokines IL-23 and IL-17, were measured using ELISA. Preoperative expression of mRNA for IL-12p35, IFN-γ, IL-23p19 and IL-17 was quantified by real-time RT-PCR using mRNA extracted from peripheral blood mononuclear cells. Eight patients developed postoperative sepsis, diagnosed within two weeks post-operation as systemic inflammatory response syndrome in the presence of local or systemic infection. The preoperative basal plasma concentrations of Th1 and Th17 cytokines were slightly above the detection limits, with a tendency toward lower concentrations in patients who developed sepsis, but the difference was not significant (p>0.05). The preoperative expression of mRNA encoding IL-12p35 and IL-17 was significantly lower in patients who developed sepsis (p=0.003 and p=0.028, respectively). The similar trend was observed for IL-23p19 and IFN-γ, but the differences did not reach the statistical significance (p=0.051 and p=0.172, respectively). These data suggest that determination of preoperative Th1 and Th17 cytokine mRNA levels might be useful in predicting sepsis development after radical cystectomy.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    TNF, IL12B, and IFNG gene polymorphisms in serbian patients with psoriasis
    (2015)
    Popadic, Svetlana (24830928800)
    ;
    Savic, Emina (24822544200)
    ;
    Markovic, Milos (7101935774)
    ;
    Ramic, Zorica (6603943950)
    ;
    Medenica, Ljiljana (16744100000)
    ;
    Pravica, Vera (7003322504)
    ;
    Spuran, Zorica (55389309000)
    ;
    Trajkovic, Vladimir (7004516866)
    ;
    Popadic, Dusan (6602255798)
    Background: Psoriasis is a common chronic inflammatory skin disease with a strong genetic basis. Cytokines such as tumor necrosis factor alpha (TNF-α), interleukins (ILs) such are IL-12 and IL-23, and interferon gamma (IFN-γ) are released from various inflammatory and resident cells, and have been implicated in the initiation/maintenance of inflammation. Certain alleles of the aforementioned cytokines may be associated with disease susceptibility/severity. Objective: To investigate the association of three common functional gene polymorphisms, namely TNF -308 G/A (rs1800629), IL12B (encoding the p40 subunit of IL-12/23) +1188 A/C (rs3212227), and IFNG +874 T/A (rs2430561) with psoriasis development and severity in Serbian patients. Methods: We genotyped 130 patients with psoriasis (26 of whom also had psoriatic arthritis) and 259 controls; rs1800629 and rs3212227, and rs2430561, by real-time PCR assay. Results: The TNF GG genotype was detected at a higher frequency in patients with psoriasis compared to control subjects (OR, 1.420; 95% CI, 0.870∼2.403) without statistical significance (p= 0.191). Lack of the TNF G allele was associated with lower psoriasis severity (p=0.007). The IL12B AC genotype was underrepresented in the patients with psoriatic arthritis compared to healthy subjects (OR, 0.308; 95% CI, 0.090∼1.057; p=0.049). The distribution of the rs2430561 allele and genotype frequencies was similar between patients with psoriasis and controls. Conclusion: Our study demonstrates an effect of the rs1800629 on psoriasis severity, and a marginal impact of the rs3212227 on susceptibility to psoriatic arthritis. Collectively, our results obtained in a Serbian cohort expand current knowledge regarding individual predisposition to psoriatic disease.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback